NanoViricides Statistics
Total Valuation
NanoViricides has a market cap or net worth of $32.07 million. The enterprise value is $30.51 million.
Important Dates
The last earnings date was Wednesday, October 15, 2025, after market close.
| Earnings Date | Oct 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoViricides has 17.43 million shares outstanding. The number of shares has increased by 27.34% in one year.
| Current Share Class | 17.43M |
| Shares Outstanding | 17.43M |
| Shares Change (YoY) | +27.34% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 7.67% |
| Float | 16.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.06 |
| P/TBV Ratio | 4.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.28
| Current Ratio | 1.28 |
| Quick Ratio | 1.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -64,373.46 |
Financial Efficiency
Return on equity (ROE) is -99.75% and return on invested capital (ROIC) is -63.16%.
| Return on Equity (ROE) | -99.75% |
| Return on Assets (ROA) | -55.39% |
| Return on Invested Capital (ROIC) | -63.16% |
| Return on Capital Employed (ROCE) | -127.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.35M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.03% in the last 52 weeks. The beta is 1.14, so NanoViricides's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +26.03% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 58.98 |
| Average Volume (20 Days) | 430,776 |
Short Selling Information
The latest short interest is 46,270, so 0.27% of the outstanding shares have been sold short.
| Short Interest | 46,270 |
| Short Previous Month | 231,929 |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.27% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.59M |
| Pretax Income | -9.47M |
| Net Income | -9.47M |
| EBITDA | -8.85M |
| EBIT | -9.59M |
| Earnings Per Share (EPS) | -$0.63 |
Full Income StatementBalance Sheet
The company has $1.56 million in cash and n/a in debt, giving a net cash position of $1.56 million or $0.09 per share.
| Cash & Cash Equivalents | 1.56M |
| Total Debt | n/a |
| Net Cash | 1.56M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 7.52M |
| Book Value Per Share | 0.45 |
| Working Capital | 364,191 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.48 million and capital expenditures -$56,964, giving a free cash flow of -$8.54 million.
| Operating Cash Flow | -8.48M |
| Capital Expenditures | -56,964 |
| Free Cash Flow | -8.54M |
| FCF Per Share | -$0.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
